| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351591A 抗炎吲哚衍生物 Indomethacin derivative |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/29/2002 | CN1351587A Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 05/29/2002 | CN1351499A Composition pharmaceutique |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351494A Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/29/2002 | CN1351487A Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
| 05/29/2002 | CN1350867A Compound oyster shell liquid |
| 05/29/2002 | CN1350862A Composition for treating leukoderma |
| 05/29/2002 | CN1350858A Electromagnetic radiation resistant antioxidizing natural medicine |
| 05/29/2002 | CN1350857A Face-beautifying ointment and its preparing process |
| 05/29/2002 | CN1350842A Lipoid and its application in medicines |
| 05/29/2002 | CN1350836A Skin dyeing composition containing mono/polycarbonyl self browning agent and flavylius salt with substituted at position 3 and usage thereof |
| 05/29/2002 | CN1085668C 6-[triazoly[3-(trifluoromethyl)phenyl)methyl]-2-quinolinones and quinolinethiones |
| 05/29/2002 | CN1085542C Oral preparation of traditional Chinese medicine medicated composition for treating psoriasis and its preparation method |
| 05/29/2002 | CN1085530C External use medicine for treating open wound |
| 05/29/2002 | CN1085522C Sun-shielding cream containing natural snow lotus |
| 05/29/2002 | CN1085521C Sapindus mukorossi pulp shampoo and its preparing process |
| 05/28/2002 | US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment |
| 05/28/2002 | US6395765 Parasiticides |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395736 Compositions and methods for the treatment of anorectal disorders |
| 05/28/2002 | US6395734 Anticancer agents |
| 05/28/2002 | US6395729 Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |
| 05/28/2002 | US6395284 Mesomorphic complex of vitamin a acid and polyethyleneimine or poly-l-amino acid; treatment of skin disorders such as acne; antitumor agents |
| 05/28/2002 | US6395281 Cosmetic skin conditioning compositions containing red yeast rice extract |
| 05/28/2002 | US6395260 Topical cosmetic compositions comprising benzaldoximes |
| 05/28/2002 | CA2254533C Treatment of pruritus |
| 05/28/2002 | CA2209513C Arachidonic acid and methods for the production and use thereof |
| 05/28/2002 | CA2090104C Stabilized retinoid-containing skin care compositions |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040529A2 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
| 05/23/2002 | WO2002040475A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040469A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040468A1 Compounds |
| 05/23/2002 | WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040034A1 Complexes of phosphate derivatives |
| 05/23/2002 | WO2002040033A1 Formulation containing phosphate derivatives of electron transfer agents |
| 05/23/2002 | WO2002040004A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039976A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 05/23/2002 | WO2002039975A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 05/23/2002 | WO2002039972A1 Insoluble organic uv filters and cosmetic use thereof |
| 05/23/2002 | WO2002039960A2 Cosmetic method of treating skin |
| 05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 05/23/2002 | WO2002005823A3 USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087884A3 Polyketide derivatives |
| 05/23/2002 | WO2001085151A3 Chimeric animal model and treatment of psoriasis |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001079164A3 N-substituted dithiocarbamates for the treatment of biological disorders |
| 05/23/2002 | WO2001078692A3 Membrane delivery system |
| 05/23/2002 | WO2001074344A3 Small organic molecule regulators of cell proliferation |
| 05/23/2002 | WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives |
| 05/23/2002 | WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
| 05/23/2002 | US20020061915 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
| 05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/23/2002 | US20020061878 Diazacycloalkanedione derivatives |
| 05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
| 05/23/2002 | US20020061865 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061832 Quaternization; used as bactericide, fungicide, algicide; and for preserving food and beverages |
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | DE10056902A1 Recovery of pure terpenes from plants, for use as pharmaceutical or cosmetic active agents, by extracting with solvent at elevated pressure and temperature then cooling and depressurizing to induce crystallization |
| 05/23/2002 | DE10056400A1 Galenische Formulierung Drug formulation |
| 05/23/2002 | DE10055588A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | DE10055469A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |